These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11413200)

  • 1. A robust neutralization test for Plasmodium falciparum malaria.
    Saul A; Miller LH
    J Exp Med; 2001 Jun; 193(12):F51-4. PubMed ID: 11413200
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.
    O'Donnell RA; de Koning-Ward TF; Burt RA; Bockarie M; Reeder JC; Cowman AF; Crabb BS
    J Exp Med; 2001 Jun; 193(12):1403-12. PubMed ID: 11413195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies and Plasmodium falciparum merozoites.
    Ramasamy R; Ramasamy M; Yasawardena S
    Trends Parasitol; 2001 Apr; 17(4):194-7. PubMed ID: 11282510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
    Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
    Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
    Saul A
    J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
    [No Abstract]   [Full Text] [Related]  

  • 7. Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria.
    Polley SD; Tetteh KK; Cavanagh DR; Pearce RJ; Lloyd JM; Bojang KA; Okenu DM; Greenwood BM; McBride JS; Conway DJ
    Infect Immun; 2003 Apr; 71(4):1833-42. PubMed ID: 12654798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
    Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates.
    Mamillapalli A; Sunil S; Diwan SS; Sharma SK; Tyagi PK; Adak T; Joshi H; Malhotra P
    Malar J; 2007 Jul; 6():95. PubMed ID: 17659072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rice-produced MSP142 of Plasmodium falciparum elicits antibodies that inhibit parasite growth in vitro.
    Chen Q; Liang W; Qian F; Qian B; Cao J; Zhang D; Xu Y; Tang L
    Parasite Immunol; 2016 Oct; 38(10):635-41. PubMed ID: 27493141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential recognition of Plasmodium falciparum merozoite surface protein 2 variants by antibodies from malaria patients in Brazil.
    Kanunfre KA; Leoratti FM; Hoffmann EH; Durlacher RR; Ferreira AW; Moraes-Avila SL; Ferreira MU
    Clin Diagn Lab Immunol; 2003 Sep; 10(5):973-6. PubMed ID: 12965937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The precursor to major merozoite surface antigens: structure and role in immunity.
    Holder AA
    Prog Allergy; 1988; 41():72-97. PubMed ID: 3043424
    [No Abstract]   [Full Text] [Related]  

  • 14. The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria.
    Holder AA
    Parasitology; 2009 Oct; 136(12):1445-56. PubMed ID: 19627632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth Cohort.
    Dent AE; Malhotra I; Wang X; Babineau D; Yeo KT; Anderson T; Kimmel RJ; Angov E; Lanar DE; Narum D; Dutta S; Richards J; Beeson JG; Crabb BS; Cowman AF; Horii T; Muchiri E; Mungai PL; King CL; Kazura JW
    Clin Vaccine Immunol; 2016 Feb; 23(2):104-16. PubMed ID: 26656119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the toolbox in pursuit of a strain transcendent malaria vaccine.
    Frosch AE; John CC
    Am J Trop Med Hyg; 2015 Jan; 92(1):1-2. PubMed ID: 25422397
    [No Abstract]   [Full Text] [Related]  

  • 17. Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria.
    Boyle MJ; Reiling L; Feng G; Langer C; Osier FH; Aspeling-Jones H; Cheng YS; Stubbs J; Tetteh KK; Conway DJ; McCarthy JS; Muller I; Marsh K; Anders RF; Beeson JG
    Immunity; 2015 Mar; 42(3):580-90. PubMed ID: 25786180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with immunoglobulin G subclass polarization in naturally acquired antibodies to Plasmodium falciparum merozoite surface proteins: a cross-sectional survey in Brazilian Amazonia.
    Scopel KK; Fontes CJ; Ferreira MU; Braga EM
    Clin Vaccine Immunol; 2006 Jul; 13(7):810-3. PubMed ID: 16829621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.
    Chitnis CE; Mukherjee P; Mehta S; Yazdani SS; Dhawan S; Shakri AR; Bhardwaj R; Gupta PK; Hans D; Mazumdar S; Singh B; Kumar S; Pandey G; Parulekar V; Imbault N; Shivyogi P; Godbole G; Mohan K; Leroy O; Singh K; Chauhan VS
    PLoS One; 2015; 10(4):e0117820. PubMed ID: 25927360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of crude Plasmodium falciparum antigens for comparison of antibody responses in patients with mild malaria vs. cerebral malaria.
    Mbengue B; Niang B; Diatta B; Tall A; Garraud O; Perraut R; Dieye A
    Iran J Immunol; 2010 Sep; 7(3):150-61. PubMed ID: 20876986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.